{"id":"234427831877-10","name":"Medtech &amp; Pharma Platform","registrationDate":"2018-06-25T10:12:10.115+02:00","category":2,"subCategory":4,"legal":"association","web":"https://www.medtech-pharma.com/home/","country":"Switzerland","headAddress":"Medtech &amp; Pharma Platform","headCity":"Basel","headPostCode":"4053","headPhone":"(41)6 13 66 71 64","boss":"Shayesteh Fürst-Ladani","bossTitle":"Ms","bossPosition":"MPP President","membersCount":2,"membersFTE":"0.75","membership":"n.a.","memberOrga":"https://www.medtech-pharma.com/home/","goal":"The Medtech &amp; Pharma Platform is an industry association using the synergies between medtech and pharmaceutical companies by establishing a forum to exchange knowledge and collaborate in technology and regulatory areas, as well as to promote product development and innovation. &#xd;<br />&#xd;<br />Future innovative healthcare solutions increasingly rely on combined products from pharma and medtech companies. Collaboration between both industries is therefore key to future innovations. &#xd;<br />&#xd;<br />The association’s goals are &#xd;<br />&#xd;<br />• Establish new industry collaboration models to ensure and accelerate market access for safe and innovative treatment options in the field of combined products.&#xd;<br />&#xd;<br />• Manage the interface between industry, policy makers, regulators and notified bodies and foster an open and transparent dialogue.&#xd;<br />&#xd;<br />• Provide a platform for joint work on a balanced and proportionate regulatory and political framework for combined products that&#xd;<br />&#xd;<br />  o facilitates innovation for the European market, it’s industries and citizens&#xd;<br />&#xd;<br />  o strengthens public health through improved patients’ access to innovative products&#xd;<br />&#xd;<br />  o reduces time to market for drugs, devices and combinations thereof&#xd;<br />&#xd;<br /> o  promotes free trade and IP principles&#xd;<br />&#xd;<br />Medtech &amp; Pharm Platform acts with a global mindset but initially focusses on European policy developments.","acronym":"MPP","interests":"Business and Industry, Communication, Competition, Consumers, Digital economy and society, Fraud prevention, General and Institutional Affairs, International co-operation and development, Public Health, Single market, Trade","euInitiatives":"The Medtech &amp; Pharma Platform Association was founded in 2017 and started its activities in 2018.&#xd;<br />&#xd;<br />The Medtech &amp; Pharma Platform monitors all EU legislative, policy and regulatory developments relating to combined products. &#xd;<br />&#xd;<br />Specifically the Medtech &amp; Pharm Platform follows:&#xd;<br />&#xd;<br />•\tMedical Device Regulation EU 2017/745 and it implementing and delegated acts as well as any related guidance document&#xd;<br />&#xd;<br />•\tIn vitro Diagnostic Regulation  EU 2017/746&#xd;<br />&#xd;<br />•\tMedicinal Product Directive EU 2001/83&#xd;<br />&#xd;<br />•\tProposal for a Regulation on Health Technology &#xd;<br />Assessment&#xd;<br />&#xd;<br />•\tGeneral Data Protection Regulation EU 2016/679&#xd;<br />&#xd;<br />•\tClinical Trials Regulation EU 536/2014&#xd;<br />&#xd;<br />•\tPolicy initiatives, projects, events and publications from DG SANTE, DG GROW, DG CONNECT, DG RESEARCH &#xd;<br />&#xd;<br />•\tHorizon 2020 / Horizon Europe","lastUp":"2018-06-25T10:21:34.897+02:00","customers":"","costAbsolu":"","costRange":"50000-99999","turnoverAbsolu":0,"turnoverRange":""}